Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
Clinical trial NCT04690920 · COMPLETED
Trial details
- NCT number
- NCT04690920
- Sponsor
- University of Lahore
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2020-12-10
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.